Is it serious to have no echo in the right ovary?

Whether the echogenicity of the right ovary is serious or not needs to be judged based on the specific cause. In most cases, it is related to physiological cysts, and in a few cases, it may indicate pathological lesions.

Anechoic areas of the ovary are commonly described on ultrasonography and usually refer to fluid-filled cystic structures. Physiological causes are more common in women of childbearing age, such as corpus luteum cysts or follicular cysts. These cysts are mostly less than 5 cm in diameter, have clear borders, and can naturally subside with the menstrual cycle. Some women may experience temporary anechoic areas due to hormonal changes before and after ovulation, accompanied by slight abdominal distension or changes in the menstrual cycle. Usually, no special treatment is required. It is recommended to review the ultrasound every 3-6 months to observe the changes.

If the echo-free area is accompanied by solid components, abnormal blood flow signals, or continues to increase, we need to be alert to the possibility of pathology. Endometriosis cysts often present with progressive dysmenorrhea and dyspareunia, and fine light spots can be seen within the cyst. Serous cystadenomas are mostly unilocular and thin-walled, while teratomas may show signs of lipid stratification. Risk factors for malignant tumors include new cysts after menopause, significantly elevated CA125, or papillary protrusions of the cyst wall. At this time, further evaluation needs to be combined with enhanced imaging or tumor markers.

It is recommended that women of childbearing age undergo ultrasound examination 3-7 days after menstruation to rule out physiological cysts. Avoid excessive pressure on the abdomen every day. If you experience persistent abdominal pain, abnormal vaginal bleeding or difficulty urinating, you should seek medical attention from a gynecologist in time. It is recommended that patients over 40 years old undergo annual gynecological examinations combined with tumor marker screening, and postmenopausal ovarian cysts should be actively evaluated regardless of size.